DSC Advisors’s Thermo Fisher Scientific TMO Stock Holding History

DSC Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-518	Closed	-$263K	–	83
2022 Q3	$263K	Sell	518 -216	-29%	-$121K	0.27%	71
2022 Q2	$399K	Sell	734 -37	-5%	-$20.4K	0.4%	48
2022 Q1	$455K	Buy	771 +358	+87%	+$206K	0.16%	57
2021 Q4	$276K	Sell	413 -20	-5%	-$12.5K	0.21%	57
2021 Q3	$247K	Buy	433 +23	+6%	+$12.6K	0.25%	56
2021 Q2	$207K	Sell	410 -270	-40%	-$127K	0.15%	70
2021 Q1	$310K	Buy	+680	New	+$325K	0.19%	59
2020 Q4	–	Sell	-493	Closed	-$218K	–	59
2020 Q3	$218K	Buy	+493	New	+$204K	0.15%	44
2020 Q1	–	Sell	-1,166	Closed	-$379K	–	73
2019 Q4	$379K	Buy	1,166 +215	+23%	+$65.2K	0.18%	45
2019 Q3	$277K	Buy	951 +159	+20%	+$45.5K	0.05%	72
2019 Q2	$233K	Sell	792 -76	-9%	-$20.9K	0.04%	72
2019 Q1	$238K	Buy	+868	New	+$216K	0.04%	69
2018 Q4	–	Sell	-1,041	Closed	-$254K	–	85
2018 Q3	$254K	Buy	+1,041	New	+$239K	0.03%	65
2018 Q2	–	Sell	-980	Closed	-$202K	–	97
2018 Q1	$202K	Buy	+980	New	+$206K	0.04%	78
2016 Q1	–	Sell	-1,616	Closed	-$229K	–	70
2015 Q4	$229K	Buy	+1,616	New	+$216K	0.12%	50

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DSC Advisors's TMO Position: Q4 2022 in Review

DSC Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 518 shares — an estimated $263K sold.

DSC Advisors first reported a position in TMO in Q4 2015 and held it in 15 quarters. The position peaked at $455K in Q1 2022. 2,376 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

DSC Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
DSC Advisors sold 518 Thermo Fisher Scientific shares in Q4 2022, an estimated $263K.
DSC Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and held it in 15 quarters.
DSC Advisors's Thermo Fisher Scientific position peaked at $455K in Q1 2022.
2,376 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on DSC Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.